DJIA 17,039.49 60.36 0.36%
NASDAQ 4,532.10 5.62 0.12%
S&P 500 1,992.37 5.86 0.29%
market minute promo

Novo Nordisk (NYSE: NVO)



company name or ticker
Company Photos
(Click to zoom)

The 3 Best Big Pharma Dividend Stocks of the Past 10 Years

Big pharma's been in a funk over the recent past with the patent cliff and the recession, but these three stocks have delivered for investors.

Novo Nordisk Raises Insulin Prices As Demand Grows

Vivus Suit Preserves Exclusivity Of Qsymia - For Now

Novo Nordisk A/S (NVO) Is Today's Pre-Market Mover With Heavy Volume Stock

Is Eli Lilly's Dividend Safe?

Here's what you need to know about Eli Lilly's dividend in the wake of patent expiration on Cymbalta and Evista.

MannKind Corporation's Date With Destiny

Will MannKind's Afrezza get approved and compete with injected mealtime insulins from Eli Lilly and Novo Nordisk.

Today's Stocks Driving Success For The Health Care Sector

MannKind Hits 52-Week High - Analyst Blog

5 Toxic Big Pharma Stocks You Need to Sell This Summer

The Importance Of Being Oral

See More Articles...